Remove Hospital Remove Safety Remove Treatments
article thumbnail

The rise of analog travel & the age of disconnection 

Spa Executive

Low-tech luxury From candlelit lodges and handwritten welcome notes to calligraphy workshops and artisanal bath rituals, hospitality brands are curating experiences that embrace craftsmanship over automation. Security, safety, and sustainability Even in a tech-free setting, guests expect high levels of security and emergency responsiveness.

article thumbnail

Should Teens Be Allowed to Undergo Non-surgical Cosmetic Procedures? Parents Weigh In

The Dermatology Digest

Mott Childrens Hospital National Poll on Childrens Health. Many parents expressed concerns about the health and safety of non-surgical cosmetic procedures and worried that their child would either grow to regret them or would want more in the future.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Dupilumab (Dupixent, Sanofi & Regeneron) Shows More Promise in BP

The Dermatology Digest

The safety and efficacy of dupilumab in BP are currently under clinical investigation and have not been evaluated by any regulatory authority. During treatment, all patients underwent a protocol-defined OCS tapering regimen if control of disease activity was maintained. 40% achieved 90% reduction in disease severity compared to 10%.

article thumbnail

How to Avoid Cosmetic Procedure Scams

West Lake Dermatology

While the most common deceitful practice is the use of counterfeit (fake) Botox or dermal fillers, other concerns include the use of outdated treatments and surgical techniques or the promise of unrealistic results. This comprehensive guide will help you recognize red flags, ask the right questions, and prioritize your safety.

Legal 36
article thumbnail

INmune Bio to Submit FDA BLA for CORDStrom in RDEB

The Dermatology Digest

The Company intends to prepare for a pre-BLA meeting to discuss particulars of its planned BLA submission, with the intent to submit a BLA in 2025 seeking approval of CORDStrom for the treatment of RDEB in pediatric patients. Anna Martinez and team at the Great Ormond Street Hospital (GOSH) London, U.K.,

article thumbnail

Arch Amenities’ Catherine Warren on technology & creating memorable experiences.

Spa Executive

We asked her about what she does, technology’s role in the hospitality and wellness space, and creating memorable experiences. Travel itself is inherently taxing on the mind and body, making it essential for hospitality providers to address these aspects to ensure a truly restorative experience.

article thumbnail

EMA’s CHMP Recommends Krystal’s Vyjuvek for Dystrophic Epidermolysis Bullosa

The Dermatology Digest

Vyjuvek (beremagene geperpavec-svdt, or B-VEC) for the treatment of wounds in patients with dystrophic epidermolysis bullosa (DEB) who have mutations in the collagen type VII alpha 1 chain (COL7A1) gene, starting from birth. The CHMPs positive opinion includes support for administration of B-VEC in either a health care setting (e.g.,

Therapy 36